Literature DB >> 3954253

Assessment of interlobar variation of bronchoalveolar lavage cellular differentials in interstitial lung diseases.

J G Garcia, R G Wolven, P L Garcia, B A Keogh.   

Abstract

Alveolitis is thought to precede permanent lung derangement in a variety of interstitial lung diseases (ILD). Bronchoalveolar lavage (BAL) cell differentials can be used to evaluate the intensity of alveolitis, whereas clinical, roentgenographic, and functional studies are insensitive monitors of lung inflammation. As ILD is generally diffuse, unilobar lavage is widely used and presumed to gauge overall lung inflammation. Consistency of lobe to lobe cell differential findings has not been systematically addressed. We analyzed 53 bilateral lobar lavages (right middle lobe and lingula) in 34 patients with sarcoidosis, idiopathic pulmonary fibrosis-collagen vascular disease (IPF-CV) and a group of mixed interstitial diseases. Cellular differentials from each lobe were independently assessed and compared. The sarcoid group, with predominantly T-lymphocytes in BAL, showed excellent interlobar correlation (r = 0.92, p less than 0.001), with only 17% showing a discrepancy of greater than 10% in percentage of T-lymphocytes. In contrast, the IPF-CV group, with predominantly neutrophils in BAL, showed good interlobar correlation (r = 0.79; p less than 0.01), but 35% had a greater than 10% discrepancy in percentage of neutrophils. Finally, the mixed group, with lymphocytes as the predominant cell in BAL, showed poor interlobar correlation (r = 0.58; p greater than 0.10), with 42% showing a greater than 10% discrepancy in percentage of lymphocytes. These results were not explicable on the basis of differences in volume of lavage fluid or total cells recovered, these parameters being remarkably consistent between lobes in the 3 patient groups and in a control group of 8 subjects without ILD. The chest roentgenogram was markedly insensitive to lavage interlobar variation.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1986        PMID: 3954253     DOI: 10.1164/arrd.1986.133.3.444

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  12 in total

1.  [Bronchoalveolar lavage].

Authors:  M Tötsch; J Guzman; D Theegarten; K W Schmid; U Costabel
Journal:  Pathologe       Date:  2007-09       Impact factor: 1.011

Review 2.  Bronchoalveolar lavage as a research tool.

Authors:  E H Walters; P V Gardiner
Journal:  Thorax       Date:  1991-09       Impact factor: 9.139

3.  Treatment with imatinib results in reduced IL-4-producing T cells, but increased CD4(+) T cells in the broncho-alveolar lavage of patients with systemic sclerosis.

Authors:  Anagha A Divekar; Dinesh Khanna; Fereidoun Abtin; Paul Maranian; Rajeev Saggar; Rajan Saggar; Daniel E Furst; Ram Raj Singh
Journal:  Clin Immunol       Date:  2011-09-05       Impact factor: 3.969

4.  Repeatability of cellular constituents and cytokine concentration in fluid obtained by non-bronchoscopic bronchoalveolar lavage of infants receiving extracorporeal oxygenation.

Authors:  R J Mildner; N A Taub; J R Vyas; H M Killer; R K Firmin; D J Field; S Kotecha
Journal:  Thorax       Date:  2001-12       Impact factor: 9.139

5.  Anatomical distribution of bronchoalveolar lavage fluid as assessed by digital subtraction radiography.

Authors:  C A Kelly; C J Kotre; C Ward; D J Hendrick; E H Walters
Journal:  Thorax       Date:  1987-08       Impact factor: 9.139

6.  Pulmonary inflammatory cells in ventilated preterm infants: effect of surfactant treatment.

Authors:  S Arnon; J Grigg; M Silverman
Journal:  Arch Dis Child       Date:  1993-07       Impact factor: 3.791

7.  Bronchoalveolar lavage of cranial and caudal lung regions in selected normal calves: cellular, microbiological, immunoglobulin, serological and histological variables.

Authors:  J K Pringle; L Viel; P E Shewen; R A Willoughby; S W Martin; V E Valli
Journal:  Can J Vet Res       Date:  1988-04       Impact factor: 1.310

8.  Prognostic value of bronchoalveolar lavage in sarcoidosis: the critical influence of disease presentation.

Authors:  K Ward; C O'Connor; C Odlum; M X Fitzgerald
Journal:  Thorax       Date:  1989-01       Impact factor: 9.139

9.  Computed tomography-guided bronchoalveolar lavage in idiopathic pulmonary fibrosis.

Authors:  C Agusti; A Xaubet; P Luburich; M C Ayuso; J Roca; R Rodriguez-Roisin
Journal:  Thorax       Date:  1996-08       Impact factor: 9.139

10.  99mTc-DTPA clearance measured by a dual head gamma camera in healthy subjects and patients with sarcoidosis. Studies of reproducibility and relation to bronchoalveolar lavage findings.

Authors:  S Thunberg; K Larsson; A Eklund; E Blaschke
Journal:  Eur J Nucl Med       Date:  1989
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.